Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance
Citations Over TimeTop 1% of 2021 papers
Abstract
The use of dedicated magnetic resonance simulation (MR-SIM) platforms in Radiation Oncology has expanded rapidly, introducing new equipment and functionality with the overall goal of improving the accuracy of radiation treatment planning. However, this emerging technology presents a new set of challenges that need to be addressed for safe and effective MR-SIM implementation. The major objectives of this report are to provide recommendations for commercially available MR simulators, including initial equipment selection, siting, acceptance testing, quality assurance, optimization of dedicated radiation therapy specific MR-SIM workflows, patient-specific considerations, safety, and staffing. Major contributions include guidance on motion and distortion management as well as MRI coil configurations to accommodate patients immobilized in the treatment position. Examples of optimized protocols and checklists for QA programs are provided. While the recommendations provided here are minimum requirements, emerging areas and unmet needs are also highlighted for future development.
Related Papers
- → Task Group 142 report: Quality assurance of medical acceleratorsa)(2009)1,566 cited
- → WE‐B‐BRA‐01: TG‐142: Quality Assurance for Medical Accelerators(2011)3 cited
- → TU-B-203-01: QA of Radiation Delivery Systems: TG-142 Quality Assurance of Medical Accelerators(2010)2 cited
- Quality assurance in planning and implementing radiation therapy.(1997)
- Commissioning and Quality Assurance of a Treatment Planning System(2017)